David Thwaites,
United Kingdom;
Leah McDermott,
Australia;
Marion Essers,
The Netherlands
4m EIVD definition, current methods and adoption
4m Limiting factors for the widespread clinical adoption of EIVD
4m The role of EIVD in Online Adaptive Radiotherapy
4m Artificial intelligence for EIVD: from Research to Clinic
How in-vivo dosimetri in brachytherapy progressed from being a measurement of dose to organs at risk to becoming a tool for treatment monitoring
Current concepts and dosimeters for in-vivo dosimetry in brachytherapy: point dosimeters and 2D panels
Requirements for in-vivo dosimetry in brachytherapy
Limitations and challenges
Future prospects: how do we transform from research to clinical application?
Symposium
Physics